Skuli SJ, Bakayoko A, Kruidenier M, Manning B, et al. Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response. Leukemia 2025 Jul 9. doi: 10.1038/s41375-025-02668.
PMID: 40634510